NCT00148148View on ClinicalTrials.gov

A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

December 31, 2007

Conditions
Hematopoietic Stem Cell TransplantationFungus Diseases
Interventions
DRUG

caspofungin

DRUG

liposomal amphotericin B

Trial Locations (1)

48145

KKS Münster University Hospital, Münster

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

University Hospital Muenster

OTHER

NCT00148148 - A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation | Biotech Hunter | Biotech Hunter